815 results on '"Huang, Tim H."'
Search Results
52. Data from Xenoestrogen-Induced Epigenetic Repression of microRNA-9-3 in Breast Epithelial Cells
53. Supplementary Table 3 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
54. Supplementary Table 5 from Diverse Gene Expression and DNA Methylation Profiles Correlate with Differential Adaptation of Breast Cancer Cells to the Antiestrogens Tamoxifen and Fulvestrant
55. Supplementary Table 2 from Xenoestrogen-Induced Epigenetic Repression of microRNA-9-3 in Breast Epithelial Cells
56. Supplementary Methods, Tables 1-2, Figures 1-6 from Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
57. Supplementary Figure 1 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
58. Supplementary Table 6 from Diverse Gene Expression and DNA Methylation Profiles Correlate with Differential Adaptation of Breast Cancer Cells to the Antiestrogens Tamoxifen and Fulvestrant
59. Supplementary Figures 1-3 from Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome
60. Supplementary Figure Legends 1-2 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
61. Supplementary Figure 1 from Xenoestrogen-Induced Epigenetic Repression of microRNA-9-3 in Breast Epithelial Cells
62. Data from Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
63. Supplementary Table 1 from Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer
64. Supplementary Table 2 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
65. Supplementary Figure 2 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
66. Supplementary Table 1 from Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
67. Supplementary Table 1 from Diverse Gene Expression and DNA Methylation Profiles Correlate with Differential Adaptation of Breast Cancer Cells to the Antiestrogens Tamoxifen and Fulvestrant
68. Supplementary Methods, Figures 1-5, Tables 1-5 from Breast Cancer–Associated Fibroblasts Confer AKT1-Mediated Epigenetic Silencing of Cystatin M in Epithelial Cells
69. Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
70. Supplementary Table 1 from Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome
71. Data from Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
72. Supplementary Figures 1-6, Tables 1-15, Methods from Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
73. Supplementary Figures 1-10, Tables 1-3 from Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells
74. Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis.
75. KLRF1 , a novel marker ofCD56 bright NKcells, predicts improved survival for patients with locally advanced bladder cancer
76. Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer
77. Epigenetic Reprogramming of Mesenchymal Stem Cells
78. A survey of computational methods in transcriptome-wide alternative splicing analysis
79. PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer
80. Epigenetics and Ovarian Cancer
81. Hypermethylation of miR-203 in endometrial carcinomas
82. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
83. Interrogating Estrogen Receptor α Signaling in Breast Cancer by Chromatin Immunoprecipitation Microarrays
84. Identifying Clinicopathological Association of DNA Hypermethylation in Cancers Using CpG Island Microarrays
85. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer
86. Cancer omics: From regulatory networks to clinical outcomes
87. Amplification of Distant Estrogen Response Elements Deregulates Target Genes Associated with Tamoxifen Resistance in Breast Cancer
88. Helicobacter pylori Causes Epigenetic Dysregulation of FOXD3 to Promote Gastric Carcinogenesis
89. KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer.
90. Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
91. Construction and Evaluation of Robust Interpretation Models for Breast Cancer Metastasis Prediction
92. Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors
93. Complete Transcriptome RNA-Seq
94. An overview of epigenetics and chemoprevention
95. Macrophages connection: aggressive nanomechanical phenotypes of circulating tumor cells in prostate cancer
96. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity
97. Cellular junction and mesenchymal factors delineate an endometriosis-specific response of endometrial stromal cells to the mesothelium
98. FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene
99. Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1
100. Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.